Produkty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2021 r
Dzienniki UE
Dz.U.UE.C.2022.29.7
Akt nienormatywny Wersja od: 20 stycznia 2022 r.
Produkty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2021 r.
(2022/C 29/04)
Podkomitet i ds. swobodnego przepływu towarów Do wiadomości Wspólnego Komitetu EOG
W nawiązaniu do decyzji Wspólnego Komitetu EOG nr 74/1999 z dnia 28 maja 1999 r. Wspólnemu Komitetowi EOG przekazuje się celem przyjęcia do wiadomości na posiedzeniu w dniu 24 września 2021 r. następujące wykazy dotyczące pozwoleń na dopuszczenie do obrotu produktów leczniczych za okres od dnia 1 stycznia do dnia 30 czerwca 2021 r.:
ZAŁĄCZNIK I Wykaz nowych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK II Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK III Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK IV Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK V Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIKI
ZAŁĄCZNIK I
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Wykaz nowych pozwoleń na dopuszczenie do obrotu
W okresie od dnia 1 stycznia do dnia 30 czerwca 2021 r. udzielono następujących pozwoleń na dopuszczenie do obrotu w państwach EFTA należących do EOG:
| Numer UE | Produkt | Państwo | Data udzielenia pozwolenia |
| EU/1/20/1515 | Abevmy | Islandia | 12.5.2021 |
| EU/1/20/1515 | Abevmy | Liechtenstein | 30.4.2021 |
| EU/1/20/1515 | Abevmy | Norwegia | 28.4.2021 |
| EU/1/20/1512 | Abirateron Accord | Liechtenstein | 30.4.2021 |
| EU/1/20/1512 | Abiraterone Accord | Islandia | 14.5.2021 |
| EU/1/20/1512 | Abiraterone Accord | Norwegia | 6.5.2021 |
| EU/1/21/1553 | Abiraterone Krka | Liechtenstein | 30.6.2021 |
| EU/1/21/1553 | Abiraterone Krka | Norwegia | 30.6.2021 |
| EU/1/20/1476 | Adakveo (warunkowo) | Liechtenstein | 15.1.2021 |
| EU/1/21/1554 | Adtralza | Liechtenstein | 30.6.2021 |
| EU/1/21/1554 | Adtralza | Norwegia | 22.6.2021 |
| EU/1/20/1509 | Alymsys | Islandia | 14.4.2021 |
| EU/1/20/1509 | Alymsys | Liechtenstein | 30.4.2021 |
| EU/1/20/1509 | Alymsys | Norwegia | 8.4.2021 |
| EU/1/20/1469 | Arikayce liposomal | Liechtenstein | 15.1.2021 |
| EU/1/20/1475 | Arsenic trioxide medac | Liechtenstein | 28.2.2021 |
| EU/2/18/228 | Arti-Cell Forte | Liechtenstein | 28.2.2021 |
| EU/1/20/1473 | Ayvakyt | Liechtenstein | 28.2.2021 |
| EU/1/18/1339 | Bevespi Aerosphere | Liechtenstein | 28.2.2021 |
| EU/2/99/017 | Bovalto Ibraxion | Liechtenstein | 28.2.2021 |
| EU/1/21/1534 | BroPair Spiromax | Islandia | 14.4.2021 |
| EU/1/21/1534 | BroPair Spiromax | Liechtenstein | 30.4.2021 |
| EU/1/21/1534 | BroPair Spiromax | Norwegia | 8.4.2021 |
| EU/2/10/112 | BTVPUR AlSap 1 | Liechtenstein | 28.2.2021 |
| EU/2/09/094 | BTVPUR AlSap 8 | Liechtenstein | 28.2.2021 |
| EU/1/20/1505 | Byfavo | Islandia | 26.4.2021 |
| EU/1/20/1505 | Byfavo | Norwegia | 8.4.2021 |
| EU/1/20/1505 | Byvafo | Liechtenstein | 30.4.2021 |
| EU/120/1448 | Cabazitaxel Accord | Liechtenstein | 28.2.2021 |
| EU/1/20/1479 | Calquence | Liechtenstein | 15.1.2021 |
| EU/1/21/1560 | Celsunax | Liechtenstein | 30.6.2021 |
| EU/1/21/1560 | Celsunax | Norwegia | 23.6.2021 |
| EU/2/20/264 | CircoMax Myco | Islandia | 4.1.2021 |
| EU/2/20/264 | CircoMax Myco | Liechtenstein | 15.1.2021 |
| EU/1/19/1395 | Clopidogrel/Acetylsalicylic acid Mylan | Liechtenstein | 28.2.2021 |
| EU/1/20/1528 | Comirnaty (warunkowo) | Liechtenstein | 15.1.2021 |
| EU/1/21/1542 | Copiktra | Islandia | 9.6.2021 |
| EU/1/21/1542 | Copiktra | Liechtenstein | 30.6.2021 |
| EU/1/21/1542 | Copiktra | Norwegia | 3.6.2021 |
| EU/2/18/230 | Cortacare | Liechtenstein | 28.2.2021 |
| EU/1/21/1529 | COVID-19 Vaccine AstraZeneca | Islandia | 29.1.2021 |
| EU/1/21/1529 | COVID-19 Vaccine AstraZeneca | Liechtenstein | 28.2.2021 |
| EU/1/20/1529 | COVID-19 Vaccine AstraZeneca (Vaxzevria) | Norwegia | 29.1.2021 |
| EU/1/20/1525 | COVID-19 Vaccine Janssen | Islandia | 11.3.2021 |
| EU/1/20/1525 | COVID-19 Vaccine Janssen | Liechtenstein | 30.4.2021 |
| EU/1/20/1525 | COVID-19 Vaccine Janssen | Norwegia | 11.3.2021 |
| EU/1/20/1507 | COVID-19 Vaccine Moderna | Islandia | 6.1.2021 |
| EU/1/20/1507 | COVID-19 Vaccine Moderna (warunkowo) | Liechtenstein | 15.1.2021 |
| EU/1/20/1507 | COVID-19 Vaccine Moderna (Spikevax) | Norwegia | 6.1.2021 |
| EU/2/21/271 | Credelio Plus | Islandia | 26.4.2021 |
| EU/2/21/271 | Credelio Plus | Liechtenstein | 30.4.2021 |
| EU/2/21/271 | Credelio Plus | Norwegia | 19.4.2021 |
| EU/1/17/1248 | Darunavir Krka d.d. | Liechtenstein | 28.2.2021 |
| EU/2/21/270 | Daxocox | Islandia | 14.5.2021 |
| EU/2/21/270 | Daxocox | Liechtenstein | 30.4.2021 |
| EU/2/21/270 | Daxocox | Norwegia | 3.6.2021 |
| EU/1/19/1412 | Deferasirox Accord | Liechtenstein | 28.2.2021 |
| EU/1/21/1547 | Drovelis | Islandia | 8.6.2021 |
| EU/1/21/1547 | Drovelis | Liechtenstein | 30.6.2021 |
| EU/1/21/1547 | Drovelis | Norwegia | 3.6.2021 |
| EU/1/18/1284 | Dzuveo | Liechtenstein | 28.2.2021 |
| EU/1/21/1549 | Efmody | Islandia | 10.6.2021 |
| EU/1/21/1549 | Efmody | Liechtenstein | 30.4.2021 |
| EU/1/21/1549 | Efmody | Norwegia | 10.6.2021 |
| EU/1/20/1504 | Elzonris | Islandia | 19.1.2021 |
| EU/1/20/1504 | Elzonris | Liechtenstein | 28.2.2021 |
| EU/1/20/1504 | Elzonris | Norwegia | 18.1.2021 |
| EU/1/18/1330 | Emgality | Liechtenstein | 28.2.2021 |
| EU/1/20/1438 | Enerzair Breezhaler | Liechtenstein | 28.2.2021 |
| EU/1/20/1508 | Enhertu | Islandia | 28.1.2021 |
| EU/1/20/1508 | Enhertu | Liechtenstein | 28.2.2021 |
| EU/1/20/1508 | Enhertu | Norwegia | 26.1.2021 |
| EU/1/21/1559 | Enspryng | Liechtenstein | 30.6.2021 |
| EU/2/20/268 | Enteroporc Coli | Islandia | 21.1.2021 |
| EU/2/20/268 | Enteroporc Coli | Liechtenstein | 15.1.2021 |
| EU/2/20/268 | Enteroporc Coli | Norwegia | 3.6.2021 |
| EU/2/20/262 | Enteroporc Coli AC | Islandia | 8.1.2021 |
| EU/2/20/262 | Enteroporc Coli AC | Liechtenstein | 15.1.2021 |
| EU/1/20/1472 | Equidacent | Liechtenstein | 15.1.2021 |
| EU/1/19/1392 | Ervebo | Liechtenstein | 28.2.2021 |
| EU/1/12/750 | Esmya | Islandia | 1.2.2021 |
| EU/1/21/1551 | Evkeeza | Liechtenstein | 30.6.2021 |
| EU/1/21/1551 | Evkeeza | Norwegia | 30.6.2021 |
| EU/1/21/1531 | Evrysdi | Islandia | 14.4.2021 |
| EU/1/21/1531 | Evrysdi | Liechtenstein | 30.4.2021 |
| EU/1/21/1531 | Evrysdi | Norwegia | 8.4.2021 |
| EU/1/20/1489 | Exparel liposomal | Liechtenstein | 28.2.2021 |
| EU/1/20/1477 | Fampridine Accord | Liechtenstein | 15.1.2021 |
| EU/1/20/1491 | Fintepla | Islandia | 22.1.2021 |
| EU/1/20/1491 | Fintepla | Liechtenstein | 15.1.2021 |
| EU/1/20/1491 | Fintepla | Norwegia | 15.1.2021 |
| EU/1/18/1326 | Flucelvax Tetra | Liechtenstein | 28.2.2021 |
| EU/1/19/1375 | Grasustek | Liechtenstein | 28.2.2021 |
| EU/1/20/1503 | Heplisav B | Islandia | 22.2.2021 |
| EU/1/20/1503 | Heplisav B | Liechtenstein | 28.2.2021 |
| EU/1/20/1503 | Heplisav B | Norwegia | 25.2.2021 |
| EU/2/20/258 | Increxxa | Liechtenstein | 28.2.2021 |
| EU/2/20/258 | Increxxa | Norwegia | 22.2.2021 |
| EU/2/17/208 | Ingelvac PCV FLEX | Liechtenstein | 28.2.2021 |
| EU/2/17/213 | Innovax-ND-IBD | Liechtenstein | 28.2.2021 |
| EU/2/20/256 | Innovax-ND-ILT | Liechtenstein | 15.1.2021 |
| EU/2/20/256 | Innovax-ND-ILT | Norwegia | 4.1.2021 |
| EU/1/20/1514 | Inrebic | Islandia | 19.2.2021 |
| EU/1/20/1514 | Inrebic | Liechtenstein | 28.2.2021 |
| EU/1/20/1514 | Inrebic | Norwegia | 11.2.2021 |
| EU/2/18/232 | Isemid | Liechtenstein | 28.2.2021 |
| EU/1/19/1396 | Ivozall | Liechtenstein | 28.2.2021 |
| EU/1/21/1557 | Jayempi | Liechtenstein | 30.6.2021 |
| EU/1/21/1557 | Jayempi | Norwegia | 30.6.2021 |
| EU/1/21/1538 | Jemperli | Islandia | 12.5.2021 |
| EU/1/21/1538 | Jemperli | Liechtenstein | 30.4.2021 |
| EU/1/21/1538 | Jemperli | Norwegia | 28.4.2021 |
| EU/1/20/1480 | Jyseleca | Liechtenstein | 15.1.2021 |
| EU/1/21/1532 | Kesimpta | Islandia | 15.4.2021 |
| EU/1/21/1532 | Kesimpta | Liechtenstein | 30.4.2021 |
| EU/1/21/1532 | Kesimpta | Norwegia | 8.4.2021 |
| EU/1/20/1506 | Kixelle | Islandia | 18.2.2021 |
| EU/1/20/1506 | Kixelle | Liechtenstein | 28.2.2021 |
| EU/1/20/1506 | Kixelle | Norwegia | 11.2.2021 |
| EU/1/21/1552 | Koselugo | Liechtenstein | 30.6.2021 |
| EU/1/21/1552 | Koselugo | Norwegia | 22.6.2021 |
| EU/1/20/1520 | Lenalidomide Krka | Islandia | 4.3.2021 |
| EU/1/20/1520 | Lenalidomide Krka | Liechtenstein | 28.2.2021 |
| EU/1/20/1520 | Lenalidomide Krka | Norwegia | 21.6.2021 |
| EU/1/20/1521 | Lenalidomide Krka d.d. | Islandia | 5.3.2021 |
| EU/1/20/1521 | Lenalidomide Krka d.d. | Liechtenstein | 30.4.2021 |
| EU/1/20/1521 | Lenalidomide Krka d.d. | Norwegia | 16.6.2021 |
| EU/1/20/1519 | Lenalidomide Krka d.d. Novo mesto | Islandia | 24.2.2021 |
| EU/1/20/1519 | Lenalidomide Krka d.d. Novo mesto | Liechtenstein | 28.2.2021 |
| EU/1/20/1519 | Lenalidomide Krka d.d. Novo mesto | Norwegia | 18.6.2021 |
| EU/1/20/1490 | Lenalidomide Mylan | Islandia | 11.1.2021 |
| EU/1/20/1490 | Lenalidomide Mylan | Liechtenstein | 28.2.2021 |
| EU/1/20/1494 | Leqvio | Islandia | 5.1.2021 |
| EU/1/20/1494 | Leqvio | Liechtenstein | 15.1.2021 |
| EU/1/20/1516 | Lextemy | Islandia | 12.5.2021 |
| EU/1/20/1516 | Lextemy | Liechtenstein | 30.4.2021 |
| EU/1/20/1516 | Lextemy | Norwegia | 28.4.2021 |
| EU/1/20/1493 | Libmeldy | Islandia | 14.1.2021 |
| EU/1/20/1493 | Libmeldy | Liechtenstein | 15.1.2021 |
| EU/1/20/1493 | Libmeldy | Norwegia | 8.1.2021 |
| EU/2/20/261 | Librela | Liechtenstein | 15.1.2021 |
| EU/2/20/261 | Librela | Norwegia | 4.1.2021 |
| EU/1/20/1470 | Lumeblue | Liechtenstein | 28.2.2021 |
| EU/1/20/1522 | Lumoxiti | Islandia | 19.2.2021 |
| EU/1/20/1522 | Lumoxiti | Liechtenstein | 28.2.2021 |
| EU/1/20/1522 | Lumoxiti | Norwegia | 11.2.2021 |
| EU/1/21/1548 | Lydisilka | Islandia | 8.6.2021 |
| EU/1/21/1548 | Lydisilka | Liechtenstein | 30.6.2021 |
| EU/1/21/1548 | Lydisilka | Norwegia | 31.5.2021 |
| EU/1/20/1483 | MenQuadfi | Liechtenstein | 15.1.2021 |
| EU/2/20/259 | Mhyosphere PCV ID | Liechtenstein | 28.2.2021 |
| EU/2/20/259 | Mhyosphere PCV ID | Norwegia | 4.1.2021 |
| EU/1/20/1445 | Mvabea | Liechtenstein | 28.2.2021 |
| EU/1/18/1325 | Namuscla | Liechtenstein | 28.2.2021 |
| EU/2/20/267 | NexGard Combo | Islandia | 25.1.2021 |
| EU/2/20/267 | NexGard Combo | Liechtenstein | 28.2.2021 |
| EU/2/20/267 | NexGard Combo | Norwegia | 20.1.2021 |
| EU/1/21/1537 | Nexpovio | Islandia | 30.3.2021 |
| EU/1/21/1537 | Nexpovio | Liechtenstein | 30.4.2021 |
| EU/1/21/1537 | Nexpovio | Norwegia | 8.4.2021 |
| EU/1/18/1290 | Nityr | Liechtenstein | 28.2.2021 |
| EU/2/20/265 | Nobivac DP Plus | Islandia | 4.1.2021 |
| EU/2/20/265 | Nobivac DP Plus | Liechtenstein | 15.1.2021 |
| EU/1/19/1364 | Nuceiva | Liechtenstein | 28.2.2021 |
| EU/1/20/1486 | Nyvepria | Liechtenstein | 15.1.2021 |
| EU/1/20/1485 | Obiltoxaximab SFL (w wyjątkowych okolicznościach) | Liechtenstein | 15.1.2021 |
| EU/1/20/1523 | Ogluo | Islandia | 22.2.2021 |
| EU/1/20/1523 | Ogluo | Liechtenstein | 28.2.2021 |
| EU/1/20/1523 | Ogluo | Norwegia | 23.2.2021 |
| EU/1/20/1499 | Onbevzi | Islandia | 19.1.2021 |
| EU/1/20/1499 | Onbevzi | Liechtenstein | 28.2.2021 |
| EU/1/20/1499 | Onbevzi | Norwegia | 15.1.2021 |
| EU/1/21/1530 | Ontozry | Islandia | 15.4.2021 |
| EU/1/21/1530 | Ontozry | Liechtenstein | 30.4.2021 |
| EU/1/21/1530 | Ontozry | Norwegia | 9.4.2021 |
| EU/1/21/1556 | Onureg | Liechtenstein | 30.6.2021 |
| EU/1/21/1556 | Onureg | Norwegia | 22.6.2021 |
| EU/1/21/1544 | Orladeyo | Islandia | 14.5.2021 |
| EU/1/21/1544 | Orladeyo | Liechtenstein | 30.6.2021 |
| EU/1/21/1544 | Orladeyo | Norwegia | 6.5.2021 |
| EU/2/20/260 | OvuGel | Liechtenstein | 28.2.2021 |
| EU/2/20/260 | OvuGel | Norwegia | 4.1.2021 |
| EU/1/20/1496 | Oxlumo | Liechtenstein | 15.1.2021 |
| EU/1/20/1510 | Oyavas | Islandia | 14.4.2021 |
| EU/1/20/1510 | Oyavas | Liechtenstein | 30.4.2021 |
| EU/1/20/1510 | Oyavas | Norwegia | 8.4.2021 |
| EU/1/20/1495 | Palforzia | Islandia | 18.1.2021 |
| EU/1/20/1495 | Palforzia | Liechtenstein | 28.2.2021 |
| EU/1/20/1495 | Palforzia | Norwegia | 15.1.2021 |
| EU/1/21/1535 | Pemazyre | Islandia | 30.3.2021 |
| EU/1/21/1535 | Pemazyre | Liechtenstein | 30.4.2021 |
| EU/1/21/1535 | Pemazyre | Norwegia | 8.4.2021 |
| EU/1/20/1487 | Phelinun | Liechtenstein | 28.2.2021 |
| EU/1/20/1497 | Phesgo | Islandia | 11.1.2021 |
| EU/1/20/1497 | Phesgo | Liechtenstein | 15.1.2021 |
| EU/1/21/1550 | Ponvory | Islandia | 9.6.2021 |
| EU/1/21/1550 | Ponvory | Liechtenstein | 30.6.2021 |
| EU/1/21/1550 | Ponvory | Norwegia | 4.6.2021 |
| EU/2/20/254 | Prevexxion RN | Liechtenstein | 28.2.2021 |
| EU/2/20/255 | Prevexxion RN+HVT+IBD | Norwegia | 4.1.2021 |
| EU/2/17/211 | Prevomax | Liechtenstein | 28.2.2021 |
| EU/1/20/1482 | Rekambys | Islandia | 11.1.2021 |
| EU/1/20/1482 | Rekambys | Liechtenstein | 15.1.2021 |
| EU/1/20/1482 | Rekambys | Norwegia | 5.1.2021 |
| EU/1/20/1527 | Retsevmo | Islandia | 19.2.2021 |
| EU/1/20/1527 | Retsevmo | Liechtenstein | 28.2.2021 |
| EU/1/20/1527 | Retsevmo | Norwegia | 11.2.2021 |
| EU/2/20/263 | Rexxolide | Islandia | 4.1.2021 |
| EU/2/20/263 | Rexxolide | Liechtenstein | 28.2.2021 |
| EU/1/19/1400 | Rhokiinsa | Liechtenstein | 28.2.2021 |
| EU/1/20/1488 | Rivaroxaban Accord | Liechtenstein | 15.1.2021 |
| EU/1/20/1502 | Roclanda | Islandia | 12.1.2021 |
| EU/1/20/1502 | Roclanda | Liechtenstein | 28.2.2021 |
| EU/1/20/1502 | Roclanda | Norwegia | 14.1.2021 |
| EU/1/20/1460 | Rozlytrek | Liechtenstein | 28.2.2021 |
| EU/1/20/1518 | Rukobia | Islandia | 19.2.2021 |
| EU/1/20/1518 | Rukobia | Liechtenstein | 28.2.2021 |
| EU/1/20/1518 | Rukobia | Norwegia | 11.2.2021 |
| EU/1/20/1431 | Ruxience | Liechtenstein | 28.2.2021 |
| EU/1/20/1435 | Sarclisa | Liechtenstein | 28.2.2021 |
| EU/1/21/1533 | Seffalair Spiromax | Islandia | 14.4.2021 |
| EU/1/21/1533 | Seffalair Spiromax | Liechtenstein | 30.4.2021 |
| EU/1/21/1533 | Seffalair Spiromax | Norwegia | 8.4.2021 |
| EU/1/20/1517 | Sibnayal | Islandia | 14.5.2021 |
| EU/1/20/1517 | Sibnayal | Liechtenstein | 30.6.2021 |
| EU/1/20/1517 | Sibnayal | Norwegia | 5.5.2021 |
| EU/1/20/1501 | Sogroya | Islandia | 15.4.2021 |
| EU/1/20/1501 | Sogroya | Liechtenstein | 30.4.2021 |
| EU/1/20/1501 | Sogroya | Norwegia | 8.4.2021 |
| EU/2/20/269 | Solensia | Liechtenstein | 28.2.2021 |
| EU/2/20/269 | Solensia | Norwegia | 14.06.2021 |
| EU/1/19/1421 | Staquis | Liechtenstein | 28.2.2021 |
| EU/1/20/1511 | Sunitinib Accord | Islandia | 4.3.2021 |
| EU/1/20/1511 | Sunitinib Accord | Liechtenstein | 30.4.2021 |
| EU/1/20/1511 | Sunitinib Accord | Norwegia | 5.3.2021 |
| EU/1/20/1484 | Supemtek | Liechtenstein | 15.1.2021 |
| EU/2/09/099 | Suvaxyn PCV | Liechtenstein | 28.2.2021 |
| EU/2/18/231 | Syvazul BTV | Liechtenstein | 28.2.2021 |
| EU/1/20/1492 | Tecartus | Islandia | 8.1.2021 |
| EU/1/20/1492 | Tecartus (warunkowo) | Liechtenstein | 15.1.2021 |
| EU/1/19/1378 | Temybric Ellipta | Liechtenstein | 28.2.2021 |
| EU/1/21/1536 | Thiotepa Riemser | Islandia | 15.4.2021 |
| EU/1/21/1536 | Thiotepa Riemser | Liechtenstein | 30.4.2021 |
| EU/1/21/1536 | Thiotepa Riemser | Norwegia | 8.4.2021 |
| EU/1/18/1351 | Trecondi | Liechtenstein | 15.1.2021 |
| EU/1/19/1419 | Trepulmix | Liechtenstein | 28.2.2021 |
| EU/1/20/1498 | Trixeo Aerosphere | Islandia | 8.1.2021 |
| EU/1/20/1498 | Trixeo Aerosphere | Liechtenstein | 28.2.2021 |
| EU/1/20/1526 | Tukysa | Islandia | 19.2.2021 |
| EU/1/20/1526 | Tukysa | Liechtenstein | 28.2.2021 |
| EU/1/20/1526 | Tukysa | Norwegia | 25.2.2021 |
| EU/2/20/257 | Tulinovet | Liechtenstein | 15.1.2021 |
| EU/2/20/252 | Tulissin | Liechtenstein | 28.2.2021 |
| EU/2/21/272 | Ultifend ND IBD | Islandia | 12.5.2021 |
| EU/2/21/272 | Ultifend ND IBD | Liechtenstein | 30.4.2021 |
| EU/2/21/272 | Ultifend ND IBD | Norwegia | 29.4.2021 |
| EU/1/20/1524 | Vazkepa | Islandia | 30.3.2021 |
| EU/1/20/1524 | Vazkepa | Liechtenstein | 30.4.2021 |
| EU/1/20/1524 | Vazkepa | Norwegia | 8.4.2021 |
| EU/2/20/266 | Vectormune FP ILT | Islandia | 5.1.2021 |
| EU/2/20/266 | Vectormune FP ILT | Liechtenstein | 15.1.2021 |
| EU/2/20/266 | Vectormune FP ILT | Norwegia | 4.1.2021 |
| EU/1/18/1298 | Veyvondi | Liechtenstein | 28.2.2021 |
| EU/1/20/1481 | Vocabria | Islandia | 26.1.2021 |
| EU/1/20/1481 | Vocabria | Liechtenstein | 28.2.2021 |
| EU/1/20/1500 | Xofluza | Islandia | 12.1.2021 |
| EU/1/20/1500 | Xofluza | Liechtenstein | 28.2.2021 |
| EU/1/20/1500 | Xofluza | Norwegia | 14.1.2021 |
| EU/1/20/1513 | Yuflyma | Islandia | 24.2.2021 |
| EU/1/20/1513 | Yuflyma | Liechtenstein | 28.2.2021 |
| EU/1/20/1513 | Yuflyma | Norwegia | 25.2.2021 |
| EU/2/17/210 | Zeleris | Liechtenstein | 28.2.2021 |
| EU/2/09/186 | Zulvac 8 Bovis | Liechtenstein | 28.2.2021 |
| EU/2/17/207 | Zulvac BTV Ovis | Liechtenstein | 28.2.2021 |
| EU/1/20/1478 | Zynrelef | Liechtenstein | 15.1.2021 |
ZAŁĄCZNIK II
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
W okresie od dnia 1 stycznia do dnia 30 czerwca 2021 r. odnowiono następujące pozwolenia na dopuszczenie do obrotu w państwach EFTA należących do EOG:
| Numer UE | Produkt | Państwo | Data udzielenia pozwolenia |
| EU/1/12/794 | ADCETRIS | Liechtenstein | 15.1.2021 |
| EU/1/16/1098 | Alprolix | Islandia | 25.2.2021 |
| EU/1/16/1098 | Alprolix | Liechtenstein | 30.4.2021 |
| EU/1/16/1098 | Alprolix | Norwegia | 23.3.2021 |
| EU/1/16/1092 | Amlodipine/Valsartan Mylan | Islandia | 25.1.2021 |
| EU/1/16/1092 | Amlodipine/Valsartan Mylan | Liechtenstein | 28.2.2021 |
| EU/1/15/1045 | Aripiprazole Accord | Liechtenstein | 15.1.2021 |
| EU/1/16/1091 | Atazanavir Mylan | Islandia | 17.5.2021 |
| EU/1/16/1091 | Atazanavir Mylan | Liechtenstein | 30.4.2021 |
| EU/1/16/1091 | Atazanavir Mylan | Norwegia | 3.5.2021 |
| EU/1/15/1074 | Benepali | Liechtenstein | 15.1.2021 |
| EU/1/20/1474 | Blenrep | Liechtenstein | 30.6.2021 |
| EU/1/16/1114 | Bortezomib Hospira | Islandia | 17.5.2021 |
| EU/1/16/1114 | Bortezomib Hospira | Liechtenstein | 30.6.2021 |
| EU/1/16/1114 | Bortezomib Hospira | Norwegia | 7.5.2021 |
| EU/1/16/1102 | Bortezomib SUN | Liechtenstein | 30.6.2021 |
| EU/1/16/1102 | Bortezomib SUN | Norwegia | 30.6.2021 |
| EU/1/13/818 | Bosulif | Islandia | 22.2.2021 |
| EU/1/13/818 | Bosulif | Norwegia | 8.3.2021 |
| EU/1/13/818 | Bosulif | Liechtenstein | 28.2.2021 |
| EU/1/15/1073 | Briviact | Liechtenstein | 15.1.2021 |
| EU/1/16/1136 | Cabometyx | Islandia | 12.5.2021 |
| EU/1/16/1136 | Cabometyx | Liechtenstein | 30.4.2021 |
| EU/1/16/1136 | Cabometyx | Norwegia | 3.5.2021 |
| EU/1/11/749 | Caprelsa | Islandia | 15.1.2021 |
| EU/1/11/749 | Caprelsa | Norwegia | 3.2.2021 |
| EU/1/11/749 | Caprelsa | Liechtenstein | 28.2.2021 |
| EU/1/15/1055 | Ciambra | Liechtenstein | 28.2.2021 |
| EU/1/15/1054 | Cinacalcet Mylan | Liechtenstein | 15.1.2021 |
| EU/1/16/1125 | Cinqaero | Islandia | 10.6.2021 |
| EU/1/16/1125 | Cinqaero | Liechtenstein | 30.6.2021 |
| EU/1/16/1125 | Cinqaero | Norwegia | 10.6.2021 |
| EU/1/16/1087 | Coagadex | Islandia | 14.4.2021 |
| EU/1/16/1087 | Coagadex | Liechtenstein | 30.4.2021 |
| EU/1/16/1087 | Coagadex | Norwegia | 7.4.2021 |
| EU/1/13/890 | Cometriq | Islandia | 11.3.2021 |
| EU/1/13/890 | Cometriq | Liechtenstein | 28.2.2021 |
| EU/1/17/1262 | Crysvita | Islandia | 2.2.2021 |
| EU/1/17/1262 | Crysvita | Liechtenstein | 28.2.2021 |
| EU/1/17/1262 | Crysvita | Norwegia | 2.2.2021 |
| EU/1/13/875 | Deltyba | Islandia | 26.4.2021 |
| EU/1/13/875 | Deltyba | Liechtenstein | 30.4.2021 |
| EU/1/16/1099 | Descovy | Islandia | 10.3.2021 |
| EU/1/16/1099 | Descovy | Liechtenstein | 28.2.2021 |
| EU/1/16/1099 | Descovy | Norwegia | 15.3.2021 |
| EU/1/15/1051 | Ebymect | Liechtenstein | 28.2.2021 |
| EU/1/15/1052 | Edistride | Liechtenstein | 28.2.2021 |
| EU/1/11/691 | Eliquis | Islandia | 19.1.2021 |
| EU/1/11/691 | Eliquis | Liechtenstein | 28.2.2021 |
| EU/1/11/691 | Eliquis | Norwegia | 18.1.2021 |
| EU/1/15/1046 | Elocta | Norwegia | 22.2.2021 |
| EU/1/16/1088 | Empliciti | Islandia | 13.1.2021 |
| EU/1/16/1088 | Empliciti | Liechtenstein | 15.1.2021 |
| EU/1/16/1105 | EndolucinBeta | Islandia | 18.2.2021 |
| EU/1/16/1105 | EndolucinBeta | Liechtenstein | 28.2.2021 |
| EU/1/16/1105 | EndolucinBeta | Norwegia | 16.2.2021 |
| EU/1/16/1116 | Epclusa | Islandia | 25.3.2021 |
| EU/1/16/1116 | Epclusa | Liechtenstein | 30.4.2021 |
| EU/1/16/1116 | Epclusa | Norwegia | 25.3.2021 |
| EU/1/15/1069 | Episalvan | Liechtenstein | 15.1.2021 |
| EU/1/15/1065 | Eptifibatid Accord | Liechtenstein | 15.1.2021 |
| EU/1/19/1392 | Ervebo | Norwegia | 3.2.2021 |
| EU/1/19/1392 | Ervebo-Ebola Zaire- Impfstoff | Liechtenstein | 15.1.2021 |
| EU/2/16/194 | Evalon | Islandia | 24.2.2021 |
| EU/2/16/194 | Evalon | Liechtenstein | 28.2.2021 |
| EU/2/16/194 | Evalon | Norwegia | 26.2.2021 |
| EU/1/15/1075 | Feraccru | Liechtenstein | 15.1.2021 |
| EU/1/16/1106 | Flixabi | Islandia | 10.3.2021 |
| EU/1/16/1106 | Flixabi | Liechtenstein | 30.4.2021 |
| EU/1/16/1106 | Flixabi | Norwegia | 7.4.2021 |
| EU/1/15/1082 | Galafold | Islandia | 25.2.2021 |
| EU/1/15/1082 | Galafold | Liechtenstein | 28.2.2021 |
| EU/1/15/1082 | Galafold | Norwegia | 23.2.2021 |
| EU/1/15/1061 | Genvoya | Liechtenstein | 28.2.2021 |
| EU/1/11/677 | Gilenya | Liechtenstein | 15.1.2021 |
| EU/1/15/1008 | Hetlioz | Liechtenstein | 28.2.2021 |
| EU/1/14/987 | Holoclar | Islandia | 25.1.2021 |
| EU/1/14/987 | Holoclar | Liechtenstein | 28.2.2021 |
| EU/1/16/1095 | Idelvion | Islandia | 18.2.2021 |
| EU/1/16/1095 | Idelvion | Liechtenstein | 28.2.2021 |
| EU/1/16/1095 | Idelvion | Norwegia | 11.2.2021 |
| EU/1/15/1064 | Imlygic | Liechtenstein | 15.1.2021 |
| EU/2/15/193 | Imrestor | Liechtenstein | 15.1.2021 |
| EU/1/11/676 | Jevtana | Islandia | 8.1.2021 |
| EU/1/11/676 | Jevtana | Liechtenstein | 15.1.2021 |
| EU/1/16/1128 | Kisplyx | Liechtenstein | 30.6.2021 |
| EU/1/16/1128 | Kisplyx | Norwegia | 22.6.2021 |
| EU/1/15/1076 | Kovaltry | Liechtenstein | 15.1.2021 |
| EU/2/16/195 | Letifend | Islandia | 24.2.2021 |
| EU/2/16/195 | Letifend | Liechtenstein | 28.2.2021 |
| EU/2/16/195 | Letifend | Norwegia | 5.3.2021 |
| EU/1/19/1376 | Libtayo | Liechtenstein | 30.6.2021 |
| EU/1/19/1376 | Libtayo | Islandia | 21.5.2021 |
| EU/1/19/1376 | Libtayo | Norwegia | 21.5.2021 |
| EU/1/16/1096 | Lonsurf | Islandia | 8.1.2021 |
| EU/1/16/1096 | Lonsurf | Liechtenstein | 15.1.2021 |
| EU/1/16/1096 | Lonsurf | Norwegia | 8.1.2021 |
| EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Liechtenstein | 15.1.2021 |
| EU/1/19/1355 | Lorviqua | Islandia | 26.4.2021 |
| EU/1/19/1355 | Lorviqua | Liechtenstein | 30.4.2021 |
| EU/1/19/1355 | Lorviqua | Norwegia | 8.4.2021 |
| EU/1/15/1078 | Natpar | Islandia | 27.4.2021 |
| EU/1/15/1078 | Natpar | Liechtenstein | 30.4.2021 |
| EU/1/15/1078 | Natpar | Norwegia | 26.4.2021 |
| EU/1/15/1053 | Neofordex | Islandia | 15.1.2021 |
| EU/1/15/1053 | Neofordex | Liechtenstein | 15.1.2021 |
| EU/1/15/1053 | Neofordex | Norwegia | 31.1.2021 |
| EU/1/16/1103 | Neparvis | Islandia | 22.2.2021 |
| EU/1/16/1103 | Neparvis | Liechtenstein | 28.2.2021 |
| EU/1/16/1103 | Neparvis | Norwegia | 16.2.2021 |
| EU/1/16/1094 | Ninlaro | Liechtenstein | 15.1.2021 |
| EU/1/16/1094 | Ninlaro | Norwegia | 22.2.2021 |
| EU/1/16/1124 | Nordimet | Liechtenstein | 30.6.2021 |
| EU/1/16/1124 | Nordimet | Norwegia | 25.6.2021 |
| EU/1/15/1035 | Obizur | Liechtenstein | 28.2.2021 |
| EU/1/16/1139 | Ocaliva | Islandia | 25.1.2021 |
| EU/1/16/1139 | Ocaliva | Norwegia | 3.2.2021 |
| EU/1/16/1139 | Ocaliva | Liechtenstein | 28.2.2021 |
| EU/1/16/1112 | Odefsey | Islandia | 19.1.2021 |
| EU/1/16/1112 | Odefsey | Liechtenstein | 28.2.2021 |
| EU/1/16/1112 | Odefsey | Norwegia | 14.1.2021 |
| EU/1/15/1070 | Oncaspar | Liechtenstein | 15.1.2021 |
| EU/1/18/1345 | Ondexxya | Islandia | 2.3.2021 |
| EU/1/18/1345 | Ondexxya | Liechtenstein | 28.2.2021 |
| EU/1/18/1345 | Ondexxya | Norwegia | 8.3.2021 |
| EU/1/15/1066 | Ongentys | Islandia | 15.3.2021 |
| EU/1/15/1066 | Ongentys | Liechtenstein | 28.2.2021 |
| EU/1/15/1066 | Ongentys | Norwegia | 15.3.2021 |
| EU/1/15/1059 | Orkambi | Liechtenstein | 15.1.2021 |
| EU/1/16/1104 | Palonosetron Accord | Islandia | 22.2.2021 |
| EU/1/16/1104 | Palonosetron Accord | Liechtenstein | 28.2.2021 |
| EU/1/16/1104 | Palonosetron Accord | Norwegia | 26.2.2021 |
| EU/1/16/1089 | Pandemiczna szczepionka przeciw grypie H5N1 AstraZeneca | Islandia | 16.3.2021 |
| EU/1/16/1089 | Pandemiczna szczepionka przeciw grypie H5N1 AstraZeneca | Liechtenstein | 30.4.2021 |
| EU/1/16/1089 | Pandemiczna szczepionka przeciw grypie H5N1 AstraZeneca | Norwegia | 24.3.2021 |
| EU/1/15/1071 | Pemetrexed Accord | Liechtenstein | 28.2.2021 |
| EU/1/16/1115 | Pemetrexed Fresenius Kabi | Islandia | 12.5.2021 |
| EU/1/16/1115 | Pemetrexed Fresenius Kabi | Liechtenstein | 30.4.2021 |
| EU/1/16/1115 | Pemetrexed Fresenius Kabi | Norwegia | 20.5.2021 |
| EU/1/15/1057 | Pemetrexed Hospira | Liechtenstein | 28.2.2021 |
| EU/1/19/1388 | Polivy | Islandia | 5.1.2021 |
| EU/1/19/1388 | Polivy | Liechtenstein | 15.1.2021 |
| EU/1/16/1108 | Qtern | Islandia | 9.6.2021 |
| EU/1/16/1108 | Qtern | Liechtenstein | 30.4.2021 |
| EU/1/16/1108 | Qtern | Norwegia | 3.6.2021 |
| EU/1/16/1090 | Rasagiline Mylan | Liechtenstein | 15.1.2021 |
| EU/1/20/1460 | Rozlytrek | Liechtenstein | 30.6.2021 |
| EU/1/17/1250 | Rubraca | Islandia | 15.3.2021 |
| EU/1/17/1250 | Rubraca | Liechtenstein | 30.4.2021 |
| EU/1/17/1250 | Rubraca | Norwegia | 11.3.2021 |
| EU/2/16/196 | Sevohale | Islandia | 14.5.2021 |
| EU/2/16/196 | Sevohale | Liechtenstein | 30.4.2021 |
| EU/2/16/196 | Sevohale | Norwegia | 7.5.2021 |
| EU/1/16/1135 | Sialanar | Liechtenstein | 30.6.2021 |
| EU/1/16/1135 | Sialanar | Norwegia | 30.6.2021 |
| EU/1/13/901 | Sirturo | Islandia | 14.1.2021 |
| EU/1/13/901 | Sirturo | Liechtenstein | 28.2.2021 |
| EU/1/13/901 | Sirturo | Norwegia | 8.2.2021 |
| EU/1/15/1072 | Spectrila | Liechtenstein | 15.1.2021 |
| EU/1/16/1097 | Strimvelis | Islandia | 14.5.2021 |
| EU/1/16/1097 | Strimvelis | Liechtenstein | 30.6.2021 |
| EU/1/16/1097 | Strimvelis | Norwegia | 7.5.2021 |
| EU/1/15/1085 | Taltz | Islandia | 29.1.2021 |
| EU/1/15/1085 | Taltz | Liechtenstein | 15.1.2021 |
| EU/1/15/1085 | Taltz | Norwegia | 14.1.2021 |
| EU/1/13/902 | Translarna | Liechtenstein | 28.2.2021 |
| EU/1/15/1083 | Uptravi | Islandia | 8.1.2021 |
| EU/1/15/1083 | Uptravi | Liechtenstein | 15.1.2021 |
| EU/1/15/1079 | Vaxelis | Liechtenstein | 15.1.2021 |
| EU/2/15/188 | Vectormune ND | Islandia | 18.2.2021 |
| EU/2/15/188 | Vectormune ND | Liechtenstein | 28.2.2021 |
| EU/1/20/1459 | Veklury | Liechtenstein | 30.6.2021 |
| EU/1/15/1068 | Wakix | Islandia | 29.1.2021 |
| EU/1/15/1068 | Wakix | Liechtenstein | 28.2.2021 |
| EU/1/19/1360 | Waylivra | Islandia | 18.2.2021 |
| EU/1/19/1360 | Waylivra | Norwegia | 1.3.2021 |
| EU/1/19/1360 | Waylivra | Liechtenstein | 28.2.2021 |
| EU/1/15/1042 | Zalviso | Liechtenstein | 15.1.2021 |
| EU/1/16/1109 | Zavicefta | Islandia | 24.2.2021 |
| EU/1/16/1109 | Zavicefta | Liechtenstein | 28.2.2021 |
| EU/1/16/1109 | Zavicefta | Norwegia | 26.2.2021 |
| EU/1/16/1119 | Zepatier | Islandia | 14.5.2021 |
| EU/1/16/1119 | Zepatier | Liechtenstein | 30.6.2021 |
| EU/1/16/1119 | Zepatier | Norwegia | 18.5.2021 |
| EU/1/11/690 | Zoely | Islandia | 25.5.2021 |
| EU/1/11/690 | Zoely | Liechtenstein | 30.6.2021 |
| EU/1/11/690 | Zoely | Norwegia | 31.5.2021 |
| EU/1/20/1443 | Zolgensma | Islandia | 8.6.2021 |
| EU/1/20/1443 | Zolgensma | Liechtenstein | 30.6.2021 |
| EU/1/20/1443 | Zolgensma | Norwegia | 2.6.2021 |
| EU/1/16/1093 | Zonisamide Mylan | Islandia | 4.1.2021 |
| EU/1/16/1093 | Zonisamide Mylan | Liechtenstein | 28.2.2021 |
ZAŁĄCZNIK III
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
W okresie od dnia 1 stycznia do dnia 30 czerwca 2021 r. udzielono następujących pozwoleń na dopuszczenie do obrotu w państwach EFTA należących do EOG:
| Numer UE | Produkt | Państwo | Data udzielenia pozwolenia |
| EU/1/13/838/006 | Aubagio | Norwegia | 22.6.2021 |
| EU/1/18/1336/009 | Buvidal | Islandia | 16.6.2021 |
| EU/1/18/1336/009 | Buvidal | Norwegia | 3.6.2021 |
| EU/1/06/367/013 | Diacomit | Islandia | 10.6.2021 |
| EU/1/06/367/013 | Diacomit | Norwegia | 10.6.2021 |
| EU/2/11/128/004-010 | Emdocam | Islandia | 25.5.2021 |
| EU/1/18/1319/009-010 | Hulio | Islandia | 18.1.2021 |
| EU/1/18/1319/009-010 | Hulio | Norwegia | 18.1.2021 |
| EU/1/20/1447/006-007 | Insulin Aspart Sanofi | Islandia | 14.5.2021 |
| EU/1/20/1447/006-007 | Insulin Aspart Sanofi | Norwegia | 4.5.2021 |
| EU/1/19/1364/002 | Nuceiva | Islandia | 29.1.2021 |
| EU/1/19/1364/002 | Nuceiva | Norwegia | 27.1.2021 |
| EU/1/14/934/007-008 | Plegridy | Islandia | 8.1.2021 |
| EU/1/08/442/025-031 | Pradaxa | Islandia | 21.1.2021 |
| EU/1/08/442/025-031 | Pradaxa | Norwegia | 19.1.2021 |
| EU/1/13/901/003 | Sirturo | Islandia | 15.4.2021 |
| EU/1/13/901/003 | Sirturo | Norwegia | 8.4.2021 |
| EU/1/19/1361/002-003 | Skyrizi | Islandia | 10.6.2021 |
| EU/1/19/1361/002-003 | Skyrizi | Norwegia | 4.6.2021 |
| EU/1/10/622/003 | Tepadina | Islandia | 15.4.2021 |
| EU/1/10/622/003 | Tepadina | Norwegia | 19.4.2021 |
| EU/1/13/892/007 | Tivicay | Islandia | 25.1.2021 |
| EU/1/13/892/007 | Tivicay | Norwegia | 18.1.2021 |
| EU/1/17/1208/006-009 | Trimbow | Islandia | 29.1.2021 |
| EU/1/17/1208/010-012 | Trimbow | Islandia | 26.4.2021 |
| EU/1/17/1208/006-009 | Trimbow | Norwegia | 26.1.2021 |
| EU/1/17/1208/010-012 | Trimbow | Norwegia | 12.4.2021 |
| EU/1/06/346/002 | Tysabri | Islandia | 15.4.2021 |
| EU/1/06/346/002 | Tysabri | Norwegia | 8.4.2021 |
| EU/1/08/472/050-051 | Xarelto | Islandia | 1.2.2021 |
| EU/1/17/472/050-051 | Xarelto | Norwegia | 26.1.2021 |
| EU/1/18/1312/003-004 | Xerava | Islandia | 2.3.2021 |
| EU/1/18/1312/003-004 | Xerava | Norwegia | 5.3.2021 |
ZAŁĄCZNIK IV
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
W okresie od dnia 1 stycznia do dnia 30 czerwca 2021 r. w państwach EFTA należących do EOG wycofano następujące pozwolenia na dopuszczenie do obrotu:
| Numer UE | Produkt | Państwo | Data wycofania |
| EU/2/08/088 | Acticam | Islandia | 26.3.2021 |
| EU/2/08/088 | Acticam | Liechtenstein | 30.4.2021 |
| EU/2/08/088 | Acticam | Norwegia | 26.3.2021 |
| EU/1/16/1122 | Aerivio Spiromax | Liechtenstein | 28.2.2021 |
| EU/1/16/1123 | Airexar Spiromax | Liechtenstein | 28.2.2021 |
| EU/1/18/1269 | Alpivab | Liechtenstein | 15.1.2021 |
| EU/1/07/390 | Altargo | Liechtenstein | 28.2.2021 |
| EU/1/10/625 | Arzerra | Liechtenstein | 28.2.2021 |
| EU/1/06/355 | ATryn | Liechtenstein | 28.2.2021 |
| EU/1/19/1382 | Azacitidin Celgene | Liechtenstein | 30.6.2021 |
| EU/1/19/1382 | Azacitidin Celgene | Islandia | 25.5.2021 |
| EU/1/19/1382 | Azacitidin Celgene | Norwegia | 16.6.2021 |
| EU/1/15/1081 | Caspofungin Accord | Islandia | 25.2.2021 |
| EU/1/15/1081 | Caspofungin Accord | Liechtenstein | 28.2.2021 |
| EU/1/10/623 | Clopidogrel/Acetylsalicylic acid Zentiva | Liechtenstein | 28.2.2021 |
| EU/1/10/623 | Clopidogrel/Acetylsalicylic acid Zentiva | Norwegia | 1.3.2021 |
| EU/1/96/024 | Crixivan | Islandia | 14.4.2021 |
| EU/1/96/024 | Crixivan | Liechtenstein | 30.4.2021 |
| EU/1/96/024 | Crixivan | Norwegia | 16.6.2021 |
| EU/1/17/1240 | Cyltezo | Liechtenstein | 28.2.2021 |
| EU/1/01/187 | DepoCyte | Liechtenstein | 28.2.2021 |
| EU/1/18/1300 | Duzallo | Liechtenstein | 28.2.2021 |
| EU/1/13/908 | Eperzan | Liechtenstein | 28.2.2021 |
| EU/1/09/510 | Fertavid | Liechtenstein | 28.2.2021 |
| EU/1/18/1288 | Halimatoz | Islandia | 12.1.2021 |
| EU/1/18/1288 | Halimatoz | Liechtenstein | 28.2.2021 |
| EU/1/18/1288 | Halimatoz | Norwegia | 9.2.2021 |
| EU/1/00/144 | Helixate NexGen | Liechtenstein | 28.2.2021 |
| EU/1/13/876 | Imatinib Medac | Liechtenstein | 28.2.2021 |
| EU/1/17/1243 | Imatinib Teva B.V. | Liechtenstein | 28.2.2021 |
| EU/1/08/505 | Intanza | Liechtenstein | 28.2.2021 |
| EU/1/01/191 | Ketek | Liechtenstein | 28.2.2021 |
| EU/1/13/895 | Kolbam | Liechtenstein | 28.2.2021 |
| EU/1/20/1516 | Lextemy | Liechtenstein | 30.6.2021 |
| EU/1/16/1162 | Lusduna | Liechtenstein | 28.2.2021 |
| EU/1/05/325 | Macugen | Liechtenstein | 28.2.2021 |
| EU/1/04/297 | Nodetrip (tidl.Xeristar) | Liechtenstein | 30.6.2021 |
| EU/1/04/297 | Nodetrip (tidl.Xeristar) | Norwegia | 16.6.2021 |
| EU/1/01/186 | Nonafact | Liechtenstein | 28.2.2021 |
| EU/1/15/1044 | Numient | Liechtenstein | 28.2.2021 |
| EU/1/14/924 | Olysio | Liechtenstein | 28.2.2021 |
| EU/1/04/287 | Osseor | Liechtenstein | 28.2.2021 |
| EU/1/00/131 | PegIntron | Islandia | 17.5.2021 |
| EU/1/00/131 | PegIntron | Liechtenstein | 30.4.2021 |
| EU/1/00/131 | PegIntron | Norwegia | 6.5.2021 |
| EU/1/15/1084 | Portrazza | Islandia | 2.3.2021 |
| EU/1/15/1084 | Portrazza | Liechtenstein | 28.2.2021 |
| EU/1/08/453 | Prepandrix | Islandia | 14.1.2021 |
| EU/1/08/453 | Prepandrix | Liechtenstein | 28.2.2021 |
| EU/1/08/453 | Prepandrix | Norwegia | 9.2.2021 |
| EU/1/04/288 | Protelos | Liechtenstein | 28.2.2021 |
| EU/1/20/1463 | Qutavina | Liechtenstein | 15.1.2021 |
| EU/1/10/634 | Ribavirin Mylan | Liechtenstein | 28.2.2021 |
| EU/1/07/388 | Sebivo | Liechtenstein | 15.1.2021 |
| EU/1/06/358 | Silgard | Liechtenstein | 28.2.2021 |
| EU/1/16/1163 | Solymbic | Liechtenstein | 28.2.2021 |
| EU/1/15/1017 | Taxespira | Liechtenstein | 28.2.2021 |
| EU/1/09/610 | Telmisartan Teva | Islandia | 9.6.2021 |
| EU/1/09/610 | Telmisartan Teva | Liechtenstein | 30.6.2021 |
| EU/1/09/610 | Telmisartan Teva | Norwegia | 16.6.2021 |
| EU/1/09/552 | Topotecan Teva | Liechtenstein | 28.2.2021 |
| EU/1/16/1126 | Truberzi | Islandia | 12.1.2021 |
| EU/1/16/1126 | Truberzi | Liechtenstein | 15.1.2021 |
| EU/1/16/1126 | Truberzi | Norwegia | 3.2.2021 |
| EU/1/18/1303 | Udenyca | Islandia | 18.2.2021 |
| EU/1/18/1303 | Udenyca | Liechtenstein | 28.2.2021 |
| EU/1/18/1303 | Udenyca | Norwegia | 15.2.2021 |
| EU/1/17/1180 | Varuby | Liechtenstein | 28.2.2021 |
| EU/1/12/752 | Vepacel | Liechtenstein | 15.1.2021 |
| EU/1/11/705 | Vibativ | Liechtenstein | 28.2.2021 |
| EU/1/11/704 | Victrelis | Liechtenstein | 28.2.2021 |
| EU/1/00/132 | ViraferonPeg | Islandia | 19.1.2021 |
| EU/1/00/132 | ViraferonPeg | Liechtenstein | 28.2.2021 |
| EU/1/00/132 | ViraferonPeg | Norwegia | 29.1.2021 |
| EU/1/11/671 | Xiapex | Liechtenstein | 28.2.2021 |
| EU/1/16/1121 | Zalmoxis | Liechtenstein | 28.2.2021 |
ZAŁĄCZNIK V
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
W okresie od dnia 1 stycznia do dnia 30 czerwca 2021 r. zawieszono następujące pozwolenia na dopuszczenie do obrotu w państwach EFTA należących do EOG:
| Numer UE | Produkt | Państwo | Data zawieszenia |
© Unia Europejska, http://eur-lex.europa.eu/
Za autentyczne uważa się wyłącznie dokumenty Unii Europejskiej opublikowane w Dzienniku Urzędowym Unii Europejskiej.